WDR5 inhibitors and modulators
US10501466B2 · kind B2 · utility
3Cited by
1References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 19, 2018 |
| Grant date | Dec 10, 2019 |
| Priority date | — |
| Expiry date | Sep 19, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/02
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Described are N-(6-(6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-2-yl)-2,3-dihydro-1H-inden-1-yl)benzamide and acetamide-containing compounds that inhibit WDR5 and associated protein-protein interactions, pharmaceutical compositions including the compounds, and methods of using the compounds and compositions for treating disorders and conditions in a subject.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.